Avalo Therapeutics Inc (NASDAQ:AVTX)

2.10
Delayed Data
As of Nov 26
 -0.07 / -3.23%
Today’s Change
2.03
Today|||52-Week Range
4.50
-20.45%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Avalo Therapeutics Inc have a median target of 5.50, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +161.90% increase from the last price of 2.10.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Avalo Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$897.5K
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.35%
 
 
 
 
 
 
Growthannually 4.31%
 
 
 
 
 
 

Sales

Growthquarterly -33.52%
 
 
 
 
 
 
Growthannually -9.06%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.